India And China Not Yet Major Sites For FDA-Regulated Trials, Parexel Finds
This article was originally published in PharmAsia News
Executive Summary
While India now ranks among the top 10 countries conducting FDA-regulated clinical trials, it has yet to see a major influx of trial work